Cancer Currents: An NCI Cancer Research Blog 4 April 2018

Cancer Immunotherapy Drug Simultaneously Targets Two Proteins that Block Immune Response

Two independent groups of researchers have fused a TGF-beta receptor to a monoclonal antibody that targets a checkpoint protein. The result is a single hybrid molecule called a Y-trap that blocks two pathways used by tumors to evade the immune system.

Read More →
Calendar